Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriella Guida

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Molecular Pharmaceutics|September 27, 2023
Enhanced Delivery of 5-Aminolevulinic Acid by Lecithin Invasomes in 3D Melanoma Cancer ModelAntonio Gaballo, Andrea Ragusa, Concetta Nobile, et al.
Experimental Dermatology|September 15, 2019
The influence of MC1R on dermal morphological features of photo-exposed skin in women revealed by reflectance confocal microscopy and optical coherence tomographyStefania Guida, Silvana Ciardo, Barbara De Pace, et al.
Pigment Cell & Melanoma Research|August 20, 2016
Detrimental effects of melanocortin-1 receptor (MC1R) variants on the clinical outcomes of BRAF V600 metastatic melanoma patients treated with BRAF inhibitorsMichele Guida, Sabino Strippoli, Anna Ferretta, et al.
Scientific Reports|March 13, 2019
Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cellsAmalia Azzariti, Rosa Maria Iacobazzi, Roberta Di Fonte, et al.
International Journal of Molecular Sciences|July 29, 2020
Tomatine Displays Antitumor Potential in In Vitro Models of Metastatic MelanomaSimona Serratì, Letizia Porcelli, Stefania Guida, et al.
Frontiers in Molecular Biosciences|March 22, 2021
The Genetic Germline Background of Single and Multiple Primary MelanomasSimona De Summa, Antonia Lasorella, Sabino Strippoli, et al.
Journal of Translational Medicine|January 13, 2019
Translational control mechanisms in cutaneous malignant melanoma: the role of eIF2αImmacolata Maida, Paola Zanna, Stefania Guida, et al.
International Journal of Molecular Sciences|January 25, 2025
Irisin and Metastatic Melanoma: Selective Anti-Invasiveness Activity in BRAF Wild-Type CellsSimona Serratì, Roberta Zerlotin, Michele Manganelli, et al.
Molecular Cancer|January 19, 2022
Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanomaSimona Serratì, Michele Guida, Roberta Di Fonte, et al.
International Journal of Pharmaceutics|December 11, 2023
Microfluidic development and biological evaluation of targeted therapy-loaded biomimetic nano system to improve the metastatic melanoma treatmentIlaria Arduino, Roberta Di Fonte, Mattia Tiboni, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Molecular Pharmaceutics|September 27, 2023
Enhanced Delivery of 5-Aminolevulinic Acid by Lecithin Invasomes in 3D Melanoma Cancer ModelAntonio Gaballo, Andrea Ragusa, Concetta Nobile, et al.
Experimental Dermatology|September 15, 2019
The influence of MC1R on dermal morphological features of photo-exposed skin in women revealed by reflectance confocal microscopy and optical coherence tomographyStefania Guida, Silvana Ciardo, Barbara De Pace, et al.
Pigment Cell & Melanoma Research|August 20, 2016
Detrimental effects of melanocortin-1 receptor (MC1R) variants on the clinical outcomes of BRAF V600 metastatic melanoma patients treated with BRAF inhibitorsMichele Guida, Sabino Strippoli, Anna Ferretta, et al.
Scientific Reports|March 13, 2019
Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cellsAmalia Azzariti, Rosa Maria Iacobazzi, Roberta Di Fonte, et al.
International Journal of Molecular Sciences|July 29, 2020
Tomatine Displays Antitumor Potential in In Vitro Models of Metastatic MelanomaSimona Serratì, Letizia Porcelli, Stefania Guida, et al.
Frontiers in Molecular Biosciences|March 22, 2021
The Genetic Germline Background of Single and Multiple Primary MelanomasSimona De Summa, Antonia Lasorella, Sabino Strippoli, et al.
Journal of Translational Medicine|January 13, 2019
Translational control mechanisms in cutaneous malignant melanoma: the role of eIF2αImmacolata Maida, Paola Zanna, Stefania Guida, et al.
International Journal of Molecular Sciences|January 25, 2025
Irisin and Metastatic Melanoma: Selective Anti-Invasiveness Activity in BRAF Wild-Type CellsSimona Serratì, Roberta Zerlotin, Michele Manganelli, et al.
Molecular Cancer|January 19, 2022
Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanomaSimona Serratì, Michele Guida, Roberta Di Fonte, et al.
International Journal of Pharmaceutics|December 11, 2023
Microfluidic development and biological evaluation of targeted therapy-loaded biomimetic nano system to improve the metastatic melanoma treatmentIlaria Arduino, Roberta Di Fonte, Mattia Tiboni, et al.
Pageof 4